Abstract
Melanoma accounts for just 1% of all skin cancers but is responsible for the majority of skin cancer deaths.1 Although surgical removal is often curative in early-stage melanoma, the risk of recurrence increases and prognosis worsens in advanced disease. We report on the case of a patient with recurrent stage 4 melanoma with metastasis to the liver. Early detection of recurrence with specialized blood tests of cancer biomarkers and treatment with integrative therapies led to an excellent response, and the patient is now in remission.
Where are your Clinical Trials?
It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized.









0 Comments